Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.86
    +0.05 (+0.06%)
     
  • GOLD FUTURES

    2,330.10
    -8.30 (-0.35%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,434.03
    -1,899.32 (-3.56%)
     
  • CMC Crypto 200

    1,390.19
    -33.91 (-2.38%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Vaccine Delivery Devices Market Worth US$ 10.84 Billion by 2031: Visiongain Research Inc

Visiongain has published a new report on Vaccine Delivery Devices Market Report 2021 to 2031. Profiles of Vaccine Delivery Devices and Forecasts By Device Type (Syringes, Jet Injectors, Micro Needles, By Route Of Administration (Intramuscular, Subcutaneous, Intradermal), By Usability (Disposable, Reusable), By End-User (Hospitals, Clinics). PLUS, Regional Market Analysis and COVID-19 Recovery Scenarios.

Global vaccine delivery devices market was valued at US$ 4.34 billion in 2020 and is projected to reach at a market value of US$ 10.84 billion by 2031. Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of vaccine delivery devices in North America region are some of the major factors that propel the vaccine delivery devices market growth.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/vaccine-delivery-devices-market-2021/#download_sampe_div

COVID-19 Impact on Vaccine Delivery Devices Market

The COVID-19 pandemic has a highly positive impact on the vaccine delivery devices market worldwide. There is a high demand for the COVID-19 vaccine worldwide due to the rising number of patients suffering from the infection. There are many leading companies that are investing a huge amount of money in the development of COVID-19 vaccine and vaccine delivery products including syringes and jet injectors.

ADVERTISEMENT

Also, there are many government bodies that are funding vaccine delivery device companies for the development and manufacturing of COVID-19 vaccine delivery devices, which is projected to drive the market growth in 2021 and 2022 at a high pace.

How this report will benefit you
Visiongain’s new study is envisioned for anyone requiring commercial in-depth analyses for the global vaccine delivery devices market along with detailed segment analysis in the market. Our new study assists you to evaluate the overall global and regional market for vaccine delivery devices. Get the financial analysis of the overall market and different segments including by device type, route of administration, usability, and end-user. High opportunity remains in this fast-growing Vaccine delivery devices market. See how to exploit the existing opportunities in the market to gain maximum advantage in the near future. In addition, the report would also help you to enhance your strategic decision making, strengthen the analysis of competitors, allows you to formulate growth strategies, and maximize the profitability of the company.

Market Drivers

Growing prevalence of rising prevalence of viral and infectious diseases including COVID-19, mounting investment in drug R&D by pharmaceutical and biopharmaceutical companies, technological advancements, government support, and developing healthcare infrastructure in emerging economies are the major drivers boosting the global vaccine delivery devices market. Medical device companies are investing huge amounts of money in R&D for the development of advanced vaccine delivery technologies and products.

There is a high demand for more efficient delivery technologies and products for the prevention of severe infectious and viral diseases. Also, there are several government organizations and campaigns that have increased the funding for the development of vaccines and delivery devices, which is projected to drive the market growth in the near future. In November 2020, BD announced that more than 800 million needles and syringes have been committed to date in support of COVID-19 vaccination programs across 12 countries and non-governmental organisations.

Get Detailed TOC @ https://www.visiongain.com/report/vaccine-delivery-devices-market-2021/#download_sampe_div

Market Opportunities

Shifting focus on adult vaccines and increasing number of vaccine awareness programs are major opportunities in the market. Furthermore, there will be greater demand for these vaccines from the population as their expectation of healthcare and standard of living increases. All of this will contribute to driving the expansion of the market.

The continuing development of the emerging countries will strengthen the global vaccine delivery devices market. As the emerging countries get richer they will be more able to ensure secure supply routes for their vaccines. This will increase the supply of vaccines within a country, fuelling the growth of the market. The sheer population of emerging markets like China and India along with the high prevalence of infectious diseases in developing countries will drive strong demand for vaccines from these countries.

Competitive Landscape

Vaccine Delivery Devices market is a highly consolidated market with several global players. Some of the major players operating in the market are F Kindeva Drug Delivery; B. Braun Medical Inc.; Becton Dickinson & Company; Corium International, Inc.; Gerresheimer AG; Hindustan Syringes & Medical Devices Limited; PharmaJet; SCHOTT AG; Smiths Medical; Terumo Corporation; Vaxxas Inc.; Gerresheimer AG; ApiJect; Verndari; Inovio Pharmaceutical Inc.; and Esperovax.

These companies are adopting several different strategies such as investment in R&D, M&A, collaborations, geographical expansion, and new product launches to gain maximum revenue share in the market. For instance, in May 2020, the U.S. Defense Department signed a $138 million contract with ApiJect Systems America for "Project Jumpstart" and "RAPID USA" will be announced by the Department of Health and Human Services.

Find qualitative and quantitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email contactus@visiongain.com

Information found nowhere else
With this new and exclusive report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your investment, research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the vaccine delivery devices market and detailed analysis of COVID-19 impact. You will get the most recent data, opportunities, trends, and predictions.

Find more research reports on the Pharma Industry click on:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.

Contact:

Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Email: sara.peerun@visiongain.com
Web: https://www.visiongain.com/
Follow Us: LinkedIn | Twitter

-

SOURCE Visiongain Limited.